In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

European CRT Survey

Hot Line III

Heart Failure (HF)

Presenter | see Discussant report

Nigussie Bogale, (Norway)

Presentation webcast

Presentation slides

List of Authors:
Kenneth Dickstein,Nigussie Bogale,Silvia Priori,Angelo Auricchio,John G. Cleland, Anselm Gitt, Tobias Limbourg,Cecilia Linde, Dirk J van Veldhuisen, Josep Brugada


European Cardiac Resynchronization Therapy Survey

The European CRT Survey is a joint initiative undertaken by the Heart Failure Association (HFA) and the European Heart Rhythm Association (EHRA) of the European Society of Cardiology. The primary aim of this Survey is to describe current European practice in terms of CRT implantations.

Methods and results:
141 centres from 13 European countries contributed data from consecutive patients successfully implanted with a CRT device with or without an ICD between November 2008 and June 2009.

2438 patients were enrolled. The median age of patients was 70 years (IQR 62-76) and 31 % were = 75 years. 78 % were in NYHA functional class III or IV and 22 % in I or II. The mean ejection fraction was 27±8% and the mean QRS duration 157±32 ms. QRS duration was <120 ms in 9%. Atrial fibrillation was reported in 23%.

26% of patients had a previously implanted permanent pacemaker or ICD. 76% of procedures were performed by an electrophysiologist. 82% had an elective admission for implantation and the median duration of hospitalisation was 3 days (IQR 2-7). 73% received a CRT-D device which was more often implanted in men, younger patients and with ischaemic aetiology. The mean QRS duration was reduced to 133±27 ms (p<0.0001) at discharge. Peri-procedural complication rates were comparable to the rates reported in randomized trials.

This CRT Survey provides important information describing current European practice with regard to patient demographics, selection criteria, procedural routines and status at discharge. These data should be useful for benchmarking individual patient management and national practice against wider experience.

Discussant | see Presenter abstract

Jean-Claude Daubert, FESC (France)

Presentation webcast





European CRT Survey

Notes to editor

This congress report accompanies a presentation given at the ESC Congress 2009. Written by the author himself/herself, this report does not necessarily reflect the opinion of the European Society of Cardiology.

The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.